These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 25728279)
21. Metabolic pathway catalyzed by Vanin-1 pantetheinase plays a suppressive role in influenza virus replication in human alveolar epithelial A549 cells. Yamashita N; Yashiro M; Ogawa H; Namba H; Nosaka N; Fujii Y; Morishima T; Tsukahara H; Yamada M Biochem Biophys Res Commun; 2017 Aug; 489(4):466-471. PubMed ID: 28576495 [TBL] [Abstract][Full Text] [Related]
22. Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production. Han S; Xu J; Guo X; Huang M Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):84-93. PubMed ID: 28853207 [TBL] [Abstract][Full Text] [Related]
23. Antiviral effect of strictinin on influenza virus replication. Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity. Ou JL; Mizushina Y; Wang SY; Chuang DY; Nadar M; Hsu WL FEBS J; 2013 Nov; 280(22):5829-40. PubMed ID: 24034558 [TBL] [Abstract][Full Text] [Related]
25. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides. Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764 [TBL] [Abstract][Full Text] [Related]
26. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes. Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593 [TBL] [Abstract][Full Text] [Related]
27. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Schloer S; Goretzko J; Kühnl A; Brunotte L; Ludwig S; Rescher U Emerg Microbes Infect; 2019; 8(1):80-93. PubMed ID: 30866762 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Pinto R; Herold S; Cakarova L; Hoegner K; Lohmeyer J; Planz O; Pleschka S Antiviral Res; 2011 Oct; 92(1):45-56. PubMed ID: 21641936 [TBL] [Abstract][Full Text] [Related]
29. Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication. Wang Z; Zhao F; Gao Q; Liu Z; Zhang Y; Li X; Li Y; Ma W; Deng T; Zhang Z; Cen S PLoS One; 2015; 10(7):e0133558. PubMed ID: 26196128 [TBL] [Abstract][Full Text] [Related]
30. 14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes. Cai W; Li Y; Chen S; Wang M; Zhang A; Zhou H; Chen H; Jin M Antiviral Res; 2015 Jun; 118():82-92. PubMed ID: 25800824 [TBL] [Abstract][Full Text] [Related]
31. In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Wang W; Zhang P; Hao C; Zhang XE; Cui ZQ; Guan HS Antiviral Res; 2011 Nov; 92(2):237-46. PubMed ID: 21867732 [TBL] [Abstract][Full Text] [Related]
32. Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. Hrincius ER; Dierkes R; Anhlan D; Wixler V; Ludwig S; Ehrhardt C Cell Microbiol; 2011 Dec; 13(12):1907-19. PubMed ID: 21899695 [TBL] [Abstract][Full Text] [Related]
33. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Nacken W; Ehrhardt C; Ludwig S Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315 [TBL] [Abstract][Full Text] [Related]
34. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication. Hsu SF; Su WC; Jeng KS; Lai MM J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of influenza virus replication by plant-derived isoquercetin. Kim Y; Narayanan S; Chang KO Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184 [TBL] [Abstract][Full Text] [Related]
36. High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy. Dai J; Wang G; Li W; Zhang L; Yang J; Zhao X; Chen X; Xu Y; Li K J Biomol Screen; 2012 Jun; 17(5):605-17. PubMed ID: 22286278 [TBL] [Abstract][Full Text] [Related]
37. Single-stranded DNA aptamer that specifically binds to the influenza virus NS1 protein suppresses interferon antagonism. Woo HM; Kim KS; Lee JM; Shim HS; Cho SJ; Lee WK; Ko HW; Keum YS; Kim SY; Pathinayake P; Kim CJ; Jeong YJ Antiviral Res; 2013 Nov; 100(2):337-45. PubMed ID: 24055449 [TBL] [Abstract][Full Text] [Related]
38. Santin inhibits influenza A virus replication through regulating MAPKs and NF-κB pathways. Zhong M; Wang HQ; Yan HY; Wu S; Gu ZY; Li YH J Asian Nat Prod Res; 2019 Dec; 21(12):1205-1214. PubMed ID: 30417663 [TBL] [Abstract][Full Text] [Related]
39. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus. Liu G; Xiong S; Xiang YF; Guo CW; Ge F; Yang CR; Zhang YJ; Wang YF; Kitazato K Arch Virol; 2011 Aug; 156(8):1359-69. PubMed ID: 21479599 [TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells. Kwok HH; Poon PY; Fok SP; Ying-Kit Yue P; Mak NK; Chan MC; Peiris JS; Wong RN Sci Rep; 2016 Jan; 6():18941. PubMed ID: 26732368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]